Full Professor(heuristic)

Lung Cancer Treatments and Mutations · Pulmonary and Respiratory Medicine

Compare more Pulmonary and Respiratory Medicine professors.

h-index62
i10-index227
Publications621
Citations22,514

Grants

2 total · 0 active

NIH #P30CA134274

Early Phase Clinical Research Support

Amount
$100K–$200K
Period
2018-08-012021-07-31
PIs
1

Awarded at UNIVERSITY OF MARYLAND BALTIMORE

NIH #R44CA250824

First in Human Phase I/II clinical trial of ONC-392: Preserving CTLA-4 immune tolerance checkpoint for safer and more effective cancer immunotherapy

Amount
$400K–$500K
Period
2020-04-032020-09-30
PIs
2

Awarded at ONCOIMMUNE, INC.

Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →

All Grants

2 total · 0 active

NIH #P30CA134274

Early Phase Clinical Research Support

Amount
$100K–$200K
Period
2018-08-012021-07-31
PIs
1

Awarded at UNIVERSITY OF MARYLAND BALTIMORE

NIH #R44CA250824

First in Human Phase I/II clinical trial of ONC-392: Preserving CTLA-4 immune tolerance checkpoint for safer and more effective cancer immunotherapy

Amount
$400K–$500K
Period
2020-04-032020-09-30
PIs
2

Awarded at ONCOIMMUNE, INC.

Recent Public Signals

  1. New paper: Supplementary Figure S1 from Cancer Incidence and Mortality Estimates in Latin America and the Caribbean: A Systematic Analysis of the GLOBOCAN 20222026-06-18

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-09-03

Data may not be current

Find elsewhere

ORCID: 0000-0002-7860-8417

Professor Insights

Career Trajectory